Mexico Genomics Market Size, Share, Trends, And Forecast 2026-2034 NGS, Public Funding, And Precision Medicine Propel 12.47% CAGR Toward USD 1.54 Billion

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Mexico Genomics Market Size, Share, Trends and Forecast by Component, Application, Technology, End-User, and Region, 2026-2034" has been added to ResearchAndMarkets.com's offering.

The Mexico genomics market reached USD 518.9 Million in 2025 and is expected to grow to USD 1.54 billion by 2034. The market is projected to record a compound annual growth rate (CAGR) of 12.47% during 2026-2034. Growth is being supported by government funding, the integration of genomics into public healthcare, institutional capacity building, international research collaborations, regulatory progress, and rising private investment.

Additional market drivers include the adoption of next-generation sequencing technologies, growing demand for personalized medicine, academic-industry partnerships, stronger intellectual property frameworks, and wider use of cloud-based analytics. Mexico's medical tourism sector is also creating opportunities for providers offering genetic testing and related clinical services.

Government Initiatives and Public Sector Investment

The Mexican government is strengthening genomic research infrastructure as part of its broader efforts to improve healthcare outcomes. Funding programs administered through institutions such as the National Institute of Genomic Medicine (INMEGEN) support genetic research, hereditary disease screening, precision medicine, and preventive healthcare initiatives.

Collaboration with international research organizations and pharmaceutical companies is improving access to advanced genomic technologies and data resources. At the same time, Mexico's regulatory environment is moving closer to global standards, supporting clinical trials, bioinformatics applications, and cross-border research partnerships.

The Mexican Biobank project represents an important development in the country's genomics ecosystem. Findings published in Nature on October 11, 2023, covered the genotyping of 6,057 individuals from 898 localities across all 32 Mexican states using 1.8 million genome-wide markers. Genome-wide association analyses were conducted for 22 complex traits, with several traits showing stronger predictive performance from Mexican Biobank data than from UK Biobank data.

Public investment in the training of geneticists, bioinformaticians, and other specialized professionals is also expanding institutional capacity. The incorporation of genomic information into health records and disease control programs further reflects Mexico's transition toward evidence-based healthcare planning.

Private Sector Participation and Technology Adoption

Private healthcare companies, multinational corporations, and regional startups are investing in next-generation sequencing, bioinformatics, genetic diagnostics, and personalized treatment platforms. Demand is particularly strong in oncology, prenatal diagnostics, pharmacogenomics, and rare disease research.

Declining global sequencing costs and the growing availability of cloud-based bioinformatics tools are encouraging laboratories, hospitals, and diagnostic centers to expand genomic services. However, local cost pressures remain a challenge. On October 11, 2023, Dr. Claudia Gonzaga-Jauregui of Universidad Nacional Autonoma de Mexico noted that sequencing costs in Mexico can be approximately two to three times higher than in the USA or Europe due to import taxes and a 16% federal tax on laboratory reagents.

Despite these barriers, local biotechnology companies are establishing academic partnerships to advance gene-editing research and rare disease models. Improved intellectual property protection and innovation incentives are also attracting venture capital and private equity. The availability of qualified personnel, scalable technologies, and regional demand for cost-effective genetic services continues to improve the outlook for market participants.

Mexico Genomics Market Segmentation

The report analyzes the Mexico genomics market by component, application, technology, end-user, and region, with forecasts covering 2026-2034.

Competitive Landscape

The report evaluates the competitive structure of the Mexico genomics market, including key player positioning, leading strategies, competitive benchmarking, and company evaluation. It also provides detailed profiles of major companies operating across genomic products, sequencing services, diagnostics, bioinformatics, pharmaceutical research, and biotechnology.

Frequently Asked Questions

How large is the Mexico genomics market?
The market was valued at USD 518.9 Million in 2025.

What is the outlook for the Mexico genomics market?
The market is forecast to reach USD 1.54 billion by 2034, expanding at a CAGR of 12.47% during 2026-2034.

What factors are driving Mexico genomics market growth?
Key growth factors include public funding, personalized medicine demand, next-generation sequencing adoption, international research partnerships, private investment, improved regulatory alignment, cloud-based analytics, and expanding genomic applications in healthcare and pharmaceutical research.

Key Attributes

Report Attribute	Details
No. of Pages	119
Forecast Period	2025-2034
Estimated Market Value (USD) in 2025	$518.9 Million
Forecasted Market Value (USD) by 2034	$1540 Million
Compound Annual Growth Rate	12.9%
Regions Covered	Mexico

Key Topics Covered
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Mexico Genomics Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Mexico Genomics Market Landscape
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 Mexico Genomics Market - Breakup by Component
6.1 Products
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Instruments and Software
6.1.3.2 Consumables and Reagents
6.1.4 Market Forecast (2026-2034)
6.2 Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Segmentation
6.2.3.1 Core Genomics Services
6.2.3.2 NGS-Based Services
6.2.3.3 Biomarker Translation Services
6.2.3.4 Computational Services
6.2.3.5 Others
6.2.4 Market Forecast (2026-2034)
7 Mexico Genomics Market - Breakup by Application
7.1 Functional Genomics
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Epigenomics
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Biomarkers Discovery
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
7.4 Pathway Analysis
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (2026-2034)
7.5 Others
7.5.1 Historical and Current Market Trends (2020-2025)
7.5.2 Market Forecast (2026-2034)
8 Mexico Genomics Market - Breakup by Technology
8.1 Sequencing
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Microarray
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Nucleic Acid Extraction and Purification
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 Mexico Genomics Market - Breakup by End-User
9.1 Research Centers
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Others
9.4.1 Historical and Current Market Trends (2020-2025)
9.4.2 Market Forecast (2026-2034)
10 Mexico Genomics Market - Breakup by Region
10.1 Northern Mexico
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Breakup by Component
10.1.4 Market Breakup by Application
10.1.5 Market Breakup by Technology
10.1.6 Market Breakup by End-User
10.1.7 Key Players
10.1.8 Market Forecast (2026-2034)
10.2 Central Mexico
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Breakup by Component
10.2.4 Market Breakup by Application
10.2.5 Market Breakup by Technology
10.2.6 Market Breakup by End-User
10.2.7 Key Players
10.2.8 Market Forecast (2026-2034)
10.3 Southern Mexico
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Breakup by Component
10.3.4 Market Breakup by Application
10.3.5 Market Breakup by Technology
10.3.6 Market Breakup by End-User
10.3.7 Key Players
10.3.8 Market Forecast (2026-2034)
10.4 Others
10.4.1 Historical and Current Market Trends (2020-2025)
10.4.2 Market Forecast (2026-2034)
11 Mexico Genomics Market - Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 Profiles of Key Players
13 Mexico Genomics Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 Appendix

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN21102026004107003653ID1111842137